Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000169.xml
Download PDF
CC BY-NC-ND 4.0 · AJP Rep 2020; 10(02): e155-e158
DOI: 10.1055/s-0040-1709513
DOI: 10.1055/s-0040-1709513
Case Report
Antibiotic Prophylaxis Trials in Obstetrics: A Call for Pediatric Collaboration
Further Information
Publication History
29 December 2019
05 March 2020
Publication Date:
15 April 2020 (online)
Abstract
Surgical site infections are common complications of cesarean delivery. Many recent studies, including meta-analyses, have assessed the efficacy of antibiotic prophylaxis. Those articles have demonstrated that preincision antibiotic prophylaxis reduces the incidence of surgical site infections postcesarean, and that the use of adjunctive azithromycin further reduces infection after nonelective cesarean deliveries. However, long-term effects of fetal exposure to antibiotic prophylaxis—including asthma, obesity, and alterations in microbiota—have also been demonstrated. We suggest that while studies of optimal antibiotic regimens proceed, considerations of the potential risks to the neonate should be factored into discussions of benefits and burdens.
-
References
- 1 Boyle A, Reddy UM. Epidemiology of cesarean delivery: the scope of the problem. Semin Perinatol 2012; 36 (05) 308-314
- 2 Costantine MM, Rahman M, Ghulmiyah L. , et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol 2008; 199 (03) 301.e1-301.e6
- 3 Conroy K, Koenig AF, Yu YH, Courtney A, Lee HJ, Norwitz ER. Infectious morbidity after cesarean delivery: 10 strategies to reduce risk. Rev Obstet Gynecol 2012; 5 (02) 69-77
- 4 Scifres CM, Leighton BL, Fogertey PJ, Macones GA, Stamilio DM. Supplemental oxygen for the prevention of postcesarean infectious morbidity: a randomized controlled trial. Am J Obstet Gynecol 2011; 205 (03) 267.e1-267.e9
- 5 Wloch C, Wilson J, Lamagni T, Harrington P, Charlett A, Sheridan E. Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG 2012; 119 (11) 1324-1333
- 6 Tita AT, Szychowski JM, Boggess K. , et al; C/SOAP Trial Consortium. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med 2016; 375 (13) 1231-1241
- 7 Caissutti C, Saccone G, Zullo F. , et al. Vaginal cleansing before cesarean delivery: a systematic review and meta-analysis. Obstet Gynecol 2017; 130 (03) 527-538
- 8 La Rosa M, Jauk V, Saade G. , et al; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium. Institutional protocols for vaginal preparation with antiseptic solution and surgical site infection rate in women undergoing cesarean delivery during labor. Obstet Gynecol 2018; 132 (02) 371-376
- 9 Harper LM, Kilgore M, Szychowski JM, Andrews WW, Tita ATN. Economic evaluation of adjunctive azithromycin prophylaxis for cesarean delivery. Obstet Gynecol 2017; 130 (02) 328-334
- 10 Blaser MJ. Our missing microbes: short-term antibiotic courses have long-term consequences. Cleve Clin J Med 2018; 85 (12) 928-930
- 11 Rodriguez J, Jordan S, Mutic A, Thul T. The neonatal microbiome: implications for neonatal intensive care unit nurses. MCN Am J Matern Child Nurs 2017; 42 (06) 332-337
- 12 Leis JA, Soong C. De-adoption of routine urine culture testing-a call to action. JAMA Intern Med 2019
- 13 Puopolo KM, Lynfield R, Cummings JJ. ; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES. Management of infants at risk for group B streptococcal disease. Pediatrics 2019; 144 (02) e20191881
- 14 Knight M, Chiocchia V, Partlett C. , et al; ANODE collaborative group. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial. Lancet 2019; 393 (10189): 2395-2403
- 15 Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med 2016; 22 (07) 713-722
- 16 Jiménez E, Marín ML, Martín R. , et al. Is meconium from healthy newborns actually sterile?. Res Microbiol 2008; 159 (03) 187-193
- 17 Cox LM, Yamanishi S, Sohn J. , et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014; 158 (04) 705-721
- 18 Corvaglia L, Tonti G, Martini S. , et al. Influence of intrapartum antibiotic prophylaxis for group B Streptococcus on gut microbiota in the first month of life. J Pediatr Gastroenterol Nutr 2016; 62 (02) 304-308
- 19 Aloisio I, Mazzola G, Corvaglia LT. , et al. Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains. Appl Microbiol Biotechnol 2014; 98 (13) 6051-6060
- 20 Mazzola G, Murphy K, Ross RP. , et al. Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B streptococcal disease. PLoS One 2016; 11 (06) e0157527
- 21 Zimmermann P, Curtis N. Effect of intrapartum antibiotics on the intestinal microbiota of infants: a systematic review. Arch Dis Child Fetal Neonatal Ed 2020; 105 (02) 201-208
- 22 Ahmadizar F, Vijverberg SJH, Arets HGM. , et al. Early life antibiotic use and the risk of asthma and asthma exacerbations in children. Pediatr Allergy Immunol 2017; 28 (05) 430-437
- 23 Yoshida S, Ide K, Takeuchi M, Kawakami K. Prenatal and early-life antibiotic use and risk of childhood asthma: a retrospective cohort study. Pediatr Allergy Immunol 2018; 29 (05) 490-495
- 24 Kashanian M, Mohtashami SS, Bemanian MH, Moosavi SAJ, Moradi Lakeh M. Evaluation of the associations between childhood asthma and prenatal and perinatal factors. Int J Gynaecol Obstet 2017; 137 (03) 290-294
- 25 Dom S, Droste JH, Sariachvili MA. , et al. Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years. Clin Exp Allergy 2010; 40 (09) 1378-1387
- 26 Sariachvili M, Droste J, Dom S. , et al. Is breast feeding a risk factor for eczema during the first year of life?. Pediatr Allergy Immunol 2007; 18 (05) 410-417
- 27 Tsakok T, McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics increase the risk of eczema? A systematic review. Br J Dermatol 2013; 169 (05) 983-991
- 28 Mueller NT, Whyatt R, Hoepner L. , et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes 2015; 39 (04) 665-670
- 29 Grimes DA, Schulz KF. False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol 2012; 120 (04) 920-927
- 30 Simioni J, Hutton EK, Gunn E. , et al. A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: the baby & microbiota of the intestine cohort study protocol. BMC Pediatr 2016; 16 (01) 183
- 31 Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ 2012; 31 (01) 219-230
- 32 Yatsunenko T, Rey FE, Manary MJ. , et al. Human gut microbiome viewed across age and geography. Nature 2012; 486 (7402): 222-227
- 33 Ben Shoham A, Bar-Meir M, Isocovich A, Samueloff A, Wiener-Well Y. Timing of antibiotic prophylaxis in cesarean section: retrospective, difference-in-differences estimation of the effect on surgical-site-infection. J Matern Fetal Neonatal Med 2019; 32 (05) 804-808
- 34 Valent AM, DeArmond C, Houston JM. , et al. Effect of post-cesarean delivery oral cephalexin and metronidazole on surgical site infection among obese women: a randomized clinical trial. JAMA 2017; 318 (11) 1026-1034